Investor
Ideas #Potcasts; #Cannabis News and #Stocks on the Move; (NYSE: $ACB) (TSXV: $VIVO.V) (TSX: $VFF.TO) (TSX: $FIRE.TO) (TSX: $TGOD.TO)
(TSXV: $XLY.V)
Delta, Kelowna, BC, November 15th, 2019 (Investorideas.com
Newswire) www.Investorideas.com, a global news source covering leading sectors
including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast
edition of cannabis news and stocks
to watch plus insight from thought leaders and experts.
Listen to the podcast:
Read this in full
at https://www.investorideas.com/news/2019/cannabis-potcasts/11151ACB-VIVO-VFF-FIRE-TGOD-XLY.asp
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
In
today’s podcast we look at a few early announcements.
But first, Athletes
For CARE (A4C), the leading athlete support care organization announced their brand new Canadian Medical Cannabis
Patient Support Program. This innovate and simple-to-use support system will
allow athletes to have easier access to medical cannabis prescriptions and
treatment, as well as key tools that will support them throughout their journey
with medical cannabis.
Athletes
for CARE is a not-for-profit organization with a community of athletes finding
support, opportunity and purpose in life after a career in sports by using
their influence for social change. Founded in 2016 by passionate individuals
who recognized the need to advocate for the health, safety and wellbeing of
more than 2 billion people of all ages who compete annually in sanctioned
sports globally.
"We're excited
to bring this new medical cannabis support program to life for our Canadian
athletes," said Christina Michael, Director, Canadian Activation, Athletes
for CARE.
"This further
strengthens our growth and ability to improve the health and wellness options
for individuals who may be living with physical and mental health challenges
and looking to medical cannabis as a potential therapeutic option to
help."
The organization
will be working alongside Strainprint® Technologies Ltd. (Strainprint), the
leader in medical cannabis data and analytics to support patients with an
Athletes For CARE version of the Strainprint app. The companion and mobile
journaling tool will help patients understand which strains and ingestion
methods work best for them.
"With more
than 70 million data points and 1.4 million tracked medical cannabis patient
outcomes and real-world observational data, we know that current and retired
athletes often face a multitude of pain and stress related issues. By aligning
with Athletes for CARE we'll be able to provide a real-time strain
recommendation guide and journaling tool that can help athletes easily
determine which strain is best suited to treat their symptoms," said
Jessica Moran, Director, Marketing & Communications for Strainprint.
"Our organization has been created by patients for patients, and we see
this as the beginning of an exciting relationship with Athletes for CARE. In
addition to providing patient support, we look forward to a future of our
mutually shared vision in advancing medical cannabis research throughout the
entire athletic community."
Athletes for CARE
is also excited to announce the involvement of Dr. Mike Hart, Cannabis
Physician and Lifestyle Strategist who in addition to participating as an
Ambassador for Athletes for CARE will be providing medical services and
treatment guidance to A4C athletes.
"Most athletes
have experienced a tremendous amount of physical trauma that has caused pain,
insomnia and poor recovery. Fortunately, many athletes have responded
favourably to cannabis; I believe every athlete should be offered cannabis as
first-line treatment," said Dr. Hart. "I am excited to broaden my
support of the athletic community through Athletes for CARE and I am equally
passionate about their mission to unite the athletic community for support,
research and education."
VIVO
Cannabis Inc. (TSX-V: VIVO) (OTCQX: VVCIF) released its third quarter 2019 financial and
operating results.
VIVO's net revenue
increased to $6.3 million during Q3 2019, a 19% increase relative to Q2 2019,
reflecting the ramp-up of the Company's increased licenced capacity which is
expected to result in further revenue growth in Q4 2019. VIVO also continued to
sustain top-tier prices for its dry flower products, with a net average selling
price of $7.15 per gram in Q3 2019.
Adjusted EBITDA was
($2.1) million in Q3 2019 compared to ($1.2) million in Q2 2019, primarily
attributable to some one-time expenses, including those associated with VIVO's
ramp-up of increased licenced capacity. As at September 30, 2019, cash and cash
equivalents (excluding strategic equity investments) were approximately $50
million.
"Our focus for
the first half of the year was to satisfy the needs of the evolving adult-use
market, provide consistent supply of quality products to medical patients, and
execute our plans for cannabis 2.0," commented Barry Fishman, Chief
Executive Officer of VIVO. "We continue to execute against our four
strategic priorities and are sharply focused on accelerating our path to
profitability."
Village
Farms International, Inc. (TSX: VFF) (NASDAQ: VFF) announced its financial results for the third
quarter and nine-month period ended September 30, 2019.
Produce sales were
US$38.3 million compared with US$39.7 million and the company had a net loss before tax of (US$6.5 million) and
included the loss from Pure Sunfarms Corp. of (US$0.9 million). Loss per share was (US$0.10) compared with
loss per share of (US$0.04) and EBITDA loss was (US$2.4 million), including the
positive contribution from Pure Sunfarms of US$5.0 million (C$6.6 million),
this compares with an EBITDA loss of (US$2.0 million); and subsequent to
quarter end, completed a bought deal offering of 3,059,000 common shares at a
price of C$9.40 per share for aggregate gross proceeds to the Company of
C$28,754,600.
"We are
pleased to report another quarter in which Pure Sunfarms continued to set the
standard for performance as a best-in-class cannabis operation, which again
drove strong financial performance," said Michael DeGiglio, Chief
Executive Officer, Village Farms.
"Pure Sunfarms' achieved its fourth consecutive quarter of positive
EBITDA, with an industry leading all-in cost of production of C$0.63, gross
margin of 69% and EBITDA margin of 56%.
In the 12 months since adult-use cannabis was legalized in Canada in
October 2018, Pure Sunfarms has already generated C$47 million in EBITDA, an
especially impressive number given that its operations were ramping up
throughout most of that period."
"Pure Sunfarms
is now proving itself as a leading cannabis brand, ranking as the number one
selling dried flower brand by a wide margin with the Ontario Cannabis Store in
October, and having the overall top selling dried flower product, as well as
three of the seven top-selling dried flower product. We look forward to Pure
Sunfarms building on this tremendous initial success as it launches its
pre-rolled dried products, adds provincial supply agreements, starts its extraction
operations online for the roll out of oils and other new product forms under
Cannabis 2.0 in the first half of next year, and more than doubles its output,
further supporting its low production costs."
The
Supreme Cannabis Company, Inc.
(TSX: FIRE) (OTCQX: SPRWF) announced the release of its financial and operating
results for the first quarter ended September 30, 2019.
The Company also
announced that it has entered into a credit agreement with Bank of Montreal as
Lead Arranger and Agent on behalf of a group of lenders for $90 million of
senior secured credit facilities consisting of a term loan of $70 million and a
revolving credit facility of $20 million.
"In the first
quarter of fiscal 2020, we operated through challenging market conditions while
integrating new businesses and product planning for the second half of the
year. Overall, our financial results
reflect the inherent difficulties of operating in a new regulated industry and
the transitionary period we are in as we evolve from a predominantly wholesale
business to a leading cannabis CPG company in Canada. Despite these challenges,
in the quarter we improved production operations to generate industry-leading
margins of 62% and made the strategic decisions necessary to position our
businesses for meaningful revenue generation from flower, flower convenience
products and select derivative products in the remainder of fiscal 2020,"
said Navdeep Dhaliwal, CEO of Supreme Cannabis. "The closing of up to $90
million in credit facilities from tier one lenders is a significant achievement
that positions the Company to execute on our strategy and prudently grow the
business in fiscal 2020 and beyond."
"In connection
with the Credit Facility, the Company underwent a rigorous due diligence
process to secure this favourable, non-dilutive financing from leading
financial institutions," continued Mr. Dhaliwal. "There is only a
select group of Canadian federal license holders who have obtained such
financing over the past year. In the current challenging operating environment,
our ability to secure credit facilities with tier one lenders speaks to the
strength of our management, business and operations, and our ability to deliver
strong financial results."
Aurora
Cannabis Inc. (NYSE: ACB) (TSX: ACB), the Canadian company defining the future
of cannabis worldwide, announced its financial and operational results for
the first quarter of fiscal 2020 ended September 30, 2019.
"Over the past
several years, Aurora has earned its place as a global leader in the cannabis
industry. Despite short term distribution and regulatory headwinds in Canada
that have temporarily impacted the industry, the long-term opportunity for
Aurora in the global cannabis and cannabinoids market is immense," said
Terry Booth, CEO, Aurora Cannabis. "Aurora has, and will continue to focus
on everything in our control. Our success in doing this was demonstrated again
this quarter by continued strong improvement in our core KPIs. We delivered
solid operating results this quarter, exemplified by our industry-leading cash
cost to produce which declined another 25% to $0.85 per gram this quarter, as well
as by our industry-leading gross margins and market share."
Mr. Booth added,
"In order to capitalize on this global market, we recognize the need to be
nimble and proactive. To enhance our financial flexibility and position us to
take maximum advantage of future growth opportunities, we have also taken
decisive steps to immediately strengthen our balance sheet. Specifically, these
steps include: (1) the announcement of a formal plan to settle our 5.0%
convertible debentures due March 2020, (2) a reduction in our capital
investments over the next several quarters by over $190 million to better match
near-term capacity expansion with anticipated demand, while maintaining our
long-term demand outlook, and (3) raising over US$124 million in gross equity
proceeds since the start of fiscal 2020 through our at-the-market
("ATM") financing program."
The
Green Organic Dutchman Holdings Ltd.
(TSX: TGOD) (OTC: TGODF) reported its financial and operational results for
the three and nine months ended September 30, 2019. These filings are available
for review on the Company's SEDAR profile at www.sedar.com.
"Q3 marked
TGOD's entry into the recreational cannabis market with a small pilot in
Ontario. We were thrilled to witness such positive feedback on product quality
and packaging from retailers and consumers across the province. Based on the initial response, demand for
high-quality flower is strong and TGOD is well positioned to capture the
premium organic segment which is significantly underserved," commented Brian
Athaide, CEO of TGOD. "Despite the challenging market conditions in
Canada, TGOD has an opportunity to be one of the first cash flow positive
cannabis companies as early as Q2 2020. We rightsized our production and our
first hybrid greenhouse is being commissioned, allowing us to produce at optimal
levels while avoiding excess inventory or incurring unnecessarily high
operating expenses. Our first harvest
from the Ancaster hybrid greenhouse is expected in December, which will enhance
our current product line and enable TGOD's first material revenues in Canada in
Q1 2020 which is very exciting," continued Athaide.
Isracann
Biosciences Inc. (CSE: IPOT) (formerly OTC: ATLED) (OTC: ISCNF) an Israel-based company focused on
becoming a premier low cost, high quality cannabis producer for both Israeli
and European export sales, announced that the Financial Industry Regulatory
Authority, Inc. ("FINRA") has approved the Company’s request to
change its OTC ticker symbol to ISCNF, effective as of the opening of market
trading today, on November 15, 2019.
The previous
trading symbol was ATLED and has been changed to more accurately represent our
corporate brand and primary operations in the cannabis sector. The Company is
also pleased to announce that it has secured DTC eligibility by The Depository
Trust Company ("DTC") for electronic settlement and transfer of its
common shares in the United States.
“Trading under the
new OTC ticker symbol ISCNF and achieving DTC eligibility is a major step
forward in making it materially easier for US-based investors who are intrigued
by the idea of buying shares in an Israeli cannabis venture operated by sector
experienced entrepreneurs and capital markets professionals. Our strategic aim
is straightforward and leverages the national brand excellence of the Israeli
agricultural industry combined with planned industrial scale production of low
cost premium quality cannabis targeting export into the massive European
marketplace. It’s a uniquely scalable venture that combines numerous positive
attributes including a team that knows how to execute,” stated Darryl Jones,
Company CEO. “This is an important step in propelling our story to wider
audiences and to materially grow our investor base."
Auxly
Cannabis Group Inc. (TSX.V: XLY) ,
together with its wholly owned subsidiary Robinsons Cannabis Inc., announced Robinsons Outdoor Grow, a large scale,
high quality outdoor cultivation project located in the heart of Nova Scotia’s
award-winning wine region of Annapolis Valley.
Robinsons OG is
uniquely located in a region that is ideal for outdoor cannabis cultivation
given its diverse soil types and microclimates; the same soil on which the
Acadians grew hemp over 250 years ago. Located within 25 kilometers of
Robinsons’ 27,700 square foot indoor facility, Robinsons OG is comprised of
over 158 acres of land in Hortonville, Nova Scotia and offers road frontage and
highway access, allowing for the potential future development of tourism and
point of sale opportunities.
Under the
leadership of cannabis industry veteran Andrew Robinson, Robinsons OG will use
a range of proprietary genetics with a track record of success in this climate
and apply several outdoor growing techniques commonly used in the fruit crop
production and wine industries.
The Robinsons OG
project is of significant strategic value to Auxly, as it provides access to
high-quality, sun grown cannabis flower for environmentally conscious consumers
and a large amount of organic biomass at lower capital and operational costs
and a lower carbon footprint relative to conventional indoor or greenhouse cultivation.
The long-term, stable supply of outdoor cannabis produced on site at Robinsons
OG will help support the product development initiatives at Dosecann Inc., the
Company’s wholly owned 52,000 square foot facility located in nearby
Charlottetown, Prince Edward Island. A substantial portion of the cannabis
produced at Robinsons OG will be used to create premium, terroir-driven
Robinsons-branded derivative cannabis products, with the same commitment to
quality and craftsmanship as Robinsons’ dried flower.
Robinsons OG
expects to submit its application and evidence of readiness to obtain a
cultivation licence under the Cannabis Act from Health Canada in Q1 2020. The Company expects the capital expenditure
for the buildout of Robinsons OG to be up to approximately $15 million (of
which approximately $6 million has already been funded, with the remainder
expected to be contributed through the first half of 2020), with expected yield
of approximately 200 kilograms per acre. Robinsons OG expects to plant approximately
20 acres in the 2020 season and responsibly scale operations in the following
years.
Hugo Alves, CEO of
Auxly, commented: “We are thrilled to announce our Robinsons OG project. As you
know, we are very excited to introduce Andrew's incredible dried cannabis
flower to discerning Canadian consumers and Robinsons OG provides us with the
perfect platform from which to expand our Robinsons branded product offering.
Under Andrew’s supervision, Robinsons OG will give us the ability to grow a
broader range of Robinsons' genetics, using Robinsons' cultivation
methodologies, and take advantage of the unique terroir of the Annapolis Valley
to bring Canadian consumers Robinsons branded cannabis products, all produced
with an unwavering commitment to quality and craftsmanship.”
Investor ideas reminds all listeners to read our
disclaimers and disclosures on the
Investorideas.com website and this podcast is not an
endorsement to buy products or services or securities. Investors are reminded
all investment involves risk and possible loss of investment
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Investorideas.com podcasts
are also available on iTunes, Spotify,
Google Play Music, Stitcher, Spreaker,
YouTube via Spreaker, iHeartradio
and Tunein.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts and
videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy and more. Investor Idea’s original branded content includes
the following podcasts and columns : Crypto Corner , Play
by Play sports and stock news column, Investor Ideas
Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech
and Climate Change , Exploring
Mining the AI
Eye .
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn
more about publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/ and
tickertagstocknews.com Global investors
must adhere to regulations of each country. Please read Investorideas.com
privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis
except where permissible by law. Our site does not possess, distribute, or sell
cannabis products.
Follow
us on Cannabis Social Media
Contact Investorideas.com
800-665-0411
No comments:
Post a Comment